Log in to save to my catalogue

Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort...

Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1607ff752aa24e119705ca9850db81ec

Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022

About this item

Full title

Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022

Publisher

Switzerland: MDPI AG

Journal title

Viruses, 2023-01, Vol.15 (1), p.201

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Background: Chile has achieved the highest coverage for vaccines against the SARS-CoV-2 virus worldwide. Objective: To assess the progression of immunity (natural and acquired by vaccine) in a cohort from two Chilean cities. Methods: Individuals (n = 386) who participated in three phases of population-based serial prevalence studies were included (...

Alternative Titles

Full title

Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1607ff752aa24e119705ca9850db81ec

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1607ff752aa24e119705ca9850db81ec

Other Identifiers

ISSN

1999-4915

E-ISSN

1999-4915

DOI

10.3390/v15010201

How to access this item